BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 34113015)

  • 21. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
    Avila-Ponce de León U; Avila-Vales E; Huang K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status.
    Bubar KM; Middleton CE; Bjorkman KK; Parker R; Larremore DB
    Nat Commun; 2022 May; 13(1):2777. PubMed ID: 35589681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Israel's rapid rollout of vaccinations for COVID-19.
    Rosen B; Waitzberg R; Israeli A
    Isr J Health Policy Res; 2021 Jan; 10(1):6. PubMed ID: 33499905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.
    Turan RD; Tastan C; Dilek Kancagi D; Yurtsever B; Sir Karakus G; Ozer S; Abanuz S; Cakirsoy D; Tumentemur G; Demir S; Seyis U; Kuzay R; Elek M; Kocaoglu ME; Ertop G; Arbak S; Acikel Elmas M; Hemsinlioglu C; Hatirnaz Ng O; Akyoney S; Sahin I; Kayhan CK; Tokat F; Akpinar G; Kasap M; Kocagoz AS; Ozbek U; Telci D; Sahin F; Yalcin K; Ratip S; Ince U; Ovali E
    Sci Rep; 2021 Aug; 11(1):15799. PubMed ID: 34349145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
    Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
    Front Immunol; 2021; 12():697074. PubMed ID: 34262569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters.
    Zhang BZ; Wang X; Yuan S; Li W; Dou Y; Poon VK; Chan CC; Cai JP; Chik KK; Tang K; Chan CC; Hu YF; Hu JC; Badea SR; Gong HR; Lin X; Chu H; Li X; To KK; Liu L; Chen Z; Hung IF; Yuen KY; Chan JF; Huang JD
    Emerg Microbes Infect; 2021 Dec; 10(1):874-884. PubMed ID: 33890550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theoretically quantifying the direct and indirect benefits of vaccination against SARS-CoV-2 in terms of avoided deaths.
    Scutt G; Cross M; Waxman D
    Sci Rep; 2022 May; 12(1):8833. PubMed ID: 35614094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2-Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization.
    Ioannou GN; Green P; Fan VS; Dominitz JA; O'Hare AM; Backus LI; Locke E; Eastment MC; Osborne TF; Ioannou NG; Berry K
    JAMA Netw Open; 2021 Apr; 4(4):e214347. PubMed ID: 33822066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
    Lien CE; Lin YJ; Chen C; Lian WC; Kuo TY; Campbell JD; Traquina P; Lin MY; Liu LT; Chuang YS; Ko HY; Liao CC; Chen YH; Jan JT; Ma HH; Sun CP; Lin YS; Wu PY; Wang YC; Tao MH; Lin YL
    Sci Rep; 2021 Apr; 11(1):8761. PubMed ID: 33888840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.
    Strafella C; Caputo V; Guerrera G; Termine A; Fabrizio C; Cascella R; Picozza M; Caltagirone C; Rossini A; Balice MP; Salvia A; Battistini L; Borsellino G; Giardina E
    Front Immunol; 2021; 12():708820. PubMed ID: 34249017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
    de Gier B; Andeweg S; Backer JA; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Nov; 26(44):. PubMed ID: 34738514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 39. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.